Swine influenza A virus vaccine comprising a nucleic acid construct having a specific order of genes
AssigneeIntervet Inc.
InventorsMark A. Mogler, Basav Hangalapura Nagaraj
Life of this patent
Estimating the term…
Loading patent…
AssigneeIntervet Inc.
InventorsMark A. Mogler, Basav Hangalapura Nagaraj
Estimating the term…
The present invention relates to a nucleic acid construct that encodes, in this order, a first Swine influenza A (IAV-S) hemagglutinin (HA) antigen of the Scot/94 lineage and a second Swine influenza A (IAV-S) hemagglutinin (HA) antigen of the Eurasian avian-like (EA) lineage, and a nucleic acid construct that encodes, in this order, a first IAV-S HA antigen of the Gent/84 lineage and a second IAV-S HA antigen of pandemic09 (pdm09) lineage. In other embodiments, the present invention relates to RNA replicon particles comprising one or both nucleic acid constructs, an immunogenic composition, such as a vaccine, which may be used against influenza A virus infections, and comprising the replicon particles. Further provided are methods of making the vaccine and use of the vaccine.
A nucleic acid construct comprising, in the order from 5′ to 3′ of its nucleic acid sequence:
A nucleic acid construct comprising, in the order from 5′ to 3′ of its nucleic acid sequence:
Dependencies are inferred from the claim text.